RSS Feeds
Search

Companies

Companies

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011 - 4 pages - $500
Liver Fibrosis Global Clinical Trials Review, Q1, 2011
Apr 2011 - 57 pages - $1,000
Liver Fibrosis Global Clinical Trials Review, H2, 2011
Sep 2011 - 83 pages - $1,000
ORG Informatics Limited (517195) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $125
CREDIT ORG OF S&M ENTPRS (8489) - Financial and Strategic SWOT Analysis Review
May 2011 - 25 pages - $125
Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010
Dec 2010 - 52 pages - $1,000
Union Memorial Hospital - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
The telecoms markets of South East Asia
Sep 2010 - 27 pages - $1,495
Liver Fibrosis - Pipeline Review, Q4 2010
Dec 2010 - 29 pages - $500
Cystic Fibrosis Global Clinical Trials Review, Q2, 2011
Jun 2011 - 74 pages - $1,000
More Related Market Research Reports >>>

Your selection

Industry sector
Non-profit org./Government del
Therapeutic target
Hospital and Surgery del
Fibrosis del
Geographic location
Asia del
Laos del

Browse By

Industry sector
Drug Information
Government
Legal
Medical information
News sources
Organizations
Patents
Professional societies
Reference sources
Regulatory
Technology transfer
Universities

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us